Ivonescimab Monotherapy or in Combination With Chemotherapy as Neoadjuvant/Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT07241819 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

II-IIIB (T3N2) Resectable Non-small Cell Lung Cancer
Perioperative

Interventions

COMBINATION_PRODUCT: Ivonescimab/surgery
COMBINATION_PRODUCT: Ivonescimab/chemotherapy/surgery
COMBINATION_PRODUCT: Ivonescimab/chemotherapy/surgery
COMBINATION_PRODUCT: Ivonescimab/chemotherapy/surgery

Sponsor

Peking University Cancer Hospital & Institute